267 related articles for article (PubMed ID: 27386780)
1. Statin-Induced Anti-HMGCR-Associated Myopathy.
Basharat P; Lahouti AH; Paik JJ; Albayda J; Pinal-Fernandez I; Bichile T; Lloyd TE; Danoff SK; Casciola-Rosen L; Mammen AL; Christopher-Stine L
J Am Coll Cardiol; 2016 Jul; 68(2):234-5. PubMed ID: 27386780
[No Abstract] [Full Text] [Related]
2. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.
Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N
Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416
[No Abstract] [Full Text] [Related]
3. Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR.
Ong SG; Ding HJ
Int J Rheum Dis; 2017 Dec; 20(12):2175-2178. PubMed ID: 26692320
[No Abstract] [Full Text] [Related]
4. Identifying statin-associated autoimmune necrotizing myopathy.
Albayda J; Christopher-Stine L
Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
[TBL] [Abstract][Full Text] [Related]
5. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
6. Commentary.
Tebo AE
Clin Chem; 2015 Sep; 61(9):1136-7. PubMed ID: 26319451
[No Abstract] [Full Text] [Related]
7. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.
Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M
Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059
[No Abstract] [Full Text] [Related]
8. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
9. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
10. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with reduced oral steroid dosage in an 81-year-old woman with statin-induced anti-HMGCR immune-mediated necrotizing myopathy.
Kondo S; Kurihara M; Higashihara M; Hara M; Nishina Y; Iwakiri R; Murayama S; Saito Y; Iwata A
Geriatr Gerontol Int; 2024 Jul; 24(7):739-742. PubMed ID: 38860537
[TBL] [Abstract][Full Text] [Related]
12. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
13. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
14. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated necrotizing myopathy due to statins exposure.
Villa L; Lerario A; Calloni S; Peverelli L; Matinato C; DE Liso F; Ceriotti F; Tironi R; Sciacco M; Moggio M; Triulzi F; Cinnante C
Acta Myol; 2018 Dec; 37(4):257-262. PubMed ID: 30944904
[TBL] [Abstract][Full Text] [Related]
16. Statin induced necrotizing autoimmune myopathy.
Babu S; Li Y
J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
[TBL] [Abstract][Full Text] [Related]
17. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.
Alvarado-Cardenas M; Marin-Sánchez A; Martínez MA; Martínez-Martínez L; Pinal-Fernandez I; Labrador-Horrillo M; Balada E; Mundet-Tuduri X; Gonzalez-Mera L; Casademont J; Acebes EM; Moreno PJ; Juarez C; Grau-Junyent JM; Pujol-Borrell R; Selva-O'Callaghan A
Autoimmun Rev; 2016 Dec; 15(12):1161-1166. PubMed ID: 27640317
[TBL] [Abstract][Full Text] [Related]
18. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
19. Regarding the mechanism of statin-induced myopathy.
Noël B
Am Heart J; 2005 Feb; 149(2):E3. PubMed ID: 15846246
[No Abstract] [Full Text] [Related]
20. Commentary.
Mammen A
Clin Chem; 2015 Sep; 61(9):1136. PubMed ID: 26319450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
